Lumos Pharma Inc (LUMO) Stock
LUMO is no longer traded. Lumos Pharma was delisted from the Nasdaq in December 2024.
Prices on this page are historical; the last trade was December 10, 2024 at $4.34.
Lumos Pharma stock price history
LUMO final trading statistics
- Final close
- $4.34
- Final trading day
- Dec 10, 2024
- Market cap at delisting
- $37.54M
- Shares outstanding
- 8.65M
- Final 52-week range
- $1.37 – $4.58
- Avg. volume (final 3 mo.)
- 84,712
- All-time high (split-adj.)
- $511.83 · Apr 2015
- All-time low (split-adj.)
- $1.45 · Jul 2024
- Return since IPO
- -93.1%
- Beta
- 0.33
- Book value / share
- $0.57
- Price / book
- 7.64
Lumos Pharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $2.05M | -$34.0M | -$4.19 |
| FY2022 | $1.52M | -$31.1M | -$3.71 |
| FY2021 | $230.0K | -$30.4M | -$3.65 |
| FY2020 | $168.0K | -$5.7M | -$0.89 |
| FY2019 | $936.0K | -$43.0M | -$9.27 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Lumos Pharma Inc
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas. As of December 12, 2024, Lumos Pharma, Inc. was taken private.
Lumos Pharma stock FAQ
What happened to Lumos Pharma stock?
Lumos Pharma stock was delisted from the Nasdaq. Its final close was $4.34 on December 10, 2024.
Is LUMO stock still trading?
No. LUMO was delisted from the Nasdaq in December 2024 and no longer trades on a U.S. exchange.
What was the last price of LUMO stock?
LUMO closed at $4.34 on its final trading day, December 10, 2024, for a market value of about $37.54M.
What were Lumos Pharma's revenue and earnings in its last full fiscal year?
Lumos Pharma reported revenue of $2.05M and net income of -$34.0M in fiscal 2023, its last full year as a public company.
When did Lumos Pharma go public?
Lumos Pharma Inc stock began trading on November 11, 2011.